0 Комментарии
0 Поделились
14 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Маркет
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Laryngeal Cancer Therapeutics Market: Global Pharmaceutical Companies, Oncology Treatment Solutions and Industry Growth Outlook"According to the latest report published by Data Bridge Market Research, the Laryngeal Cancer Therapeutics Market CAGR Value The global laryngeal cancer therapeutics market size was valued at USD 4.53 billion in 2025 and is expected to reach USD 6.44 billion by 2033, at a CAGR of 4.50% during the forecast period The Laryngeal Cancer Therapeutics Market analysis report...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Peptide Based Cancer Therapeutics Market Trends in Targeted OncologyValued at USD 8.58 billion in 2019, the peptide based cancer therapeutics market is projected to reach USD 17.18 billion by 2027, growing at a CAGR of 9.1% during the forecast period 2020–2027. Growth is attributed to innovations in peptide based cancer treatment approaches, the growing prevalence of different cancer types, high-efficacy peptide drugs, and rising pharmaceutical interest...0 Комментарии 0 Поделились 388 Просмотры 0 предпросмотр
-
Injectable Targeted Therapy Market Size, Share, Trends & Forecast 2033According to the latest report published by Data Bridge Market Research, the Injectable Targeted Therapy Market CAGR Value Injectable Targeted Therapy Market survey report is intended to help the readers develop a practical and intelligent approach to market dynamics and exploit opportunities, therefore. The market report also contains the drivers and restraints for the...0 Комментарии 0 Поделились 40 Просмотры 0 предпросмотр
-
Daratumumab Injection Market: Competitive Landscape, Strategic Collaborations, and the Rise of Subcutaneous FormulationsThe Daratumumab Injection Market is a dynamic and highly competitive sector characterized by intense research and development activities, strategic collaborations, and a relentless pursuit of innovation. As the market is projected to reach USD 7.0 billion by 2035, growing at a CAGR of 10.1%, key players are actively seeking to differentiate themselves through advanced product...0 Комментарии 0 Поделились 5Кб Просмотры 0 предпросмотр
-
Pertuzumab Market Size, Share, Trends & Forecast 2033According to the latest report published by Data Bridge Market Research, the Pertuzumab Market CAGR Value This Pertuzumab Marketdocument provides with CAGR value fluctuation during the forecast period for the market. The report provides wide-ranging statistical analysis of the market’s continuous positive developments, capacity, production, production value, cost/profit,...0 Комментарии 0 Поделились 25 Просмотры 0 предпросмотр
-
Regional Growth Prospects for the Ovarian Cancer Drugs MarketThe Ovarian Cancer Drugs Market is evolving as the need for effective cancer treatments increases worldwide. Valued at USD 3.4 billion in 2022, the Ovarian Cancer Drugs Market is projected to reach USD 5.7 billion by 2030, expanding at a CAGR of 6.6% from 2023 to 2030. Growing ovarian cancer incidence, advances in targeted medicines, and the development of innovative therapies are supporting...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek